4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
11.34
+1.34 (13.40%)
At close: Oct 24, 2025, 4:00 PM EDT
11.25
-0.09 (-0.79%)
After-hours: Oct 24, 2025, 7:37 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $529.61 million as of October 24, 2025. Its market cap has increased by 13.23% in one year.
Market Cap
529.61M
Enterprise Value
135.65M
1-Year Change
13.23%
Ranking
Category
Stock Price
$11.34
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $529.61M, a decrease of -8.75%. That is a compound annual growth rate of -1.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 529.61M | 105.68% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
| Dec 11, 2020 | 580.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 745.04B |
| Johnson & Johnson | 457.12B |
| AbbVie | 402.95B |
| UnitedHealth Group | 329.08B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.24B |
| Abbott Laboratories | 220.81B |